Perceptive Advisors as of Dec. 31, 2012
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 70 positions in its portfolio as reported in the December 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Sarepta Therapeutics (SRPT) | 17.8 | $112M | 1.4M | 77.40 | |
Infinity Pharmaceuticals (INFIQ) | 14.2 | $89M | 2.5M | 35.00 | |
Aegerion Pharmaceuticals | 10.6 | $66M | 2.6M | 25.38 | |
Repros Therapeutics | 7.2 | $45M | 2.9M | 15.75 | |
Neurocrine Biosciences (NBIX) | 4.9 | $31M | 4.1M | 7.48 | |
Celsion Corporation | 4.0 | $25M | 3.1M | 8.19 | |
Capital Senior Living Corporation | 3.6 | $23M | 1.2M | 18.69 | |
Acelrx Pharmaceuticals | 3.4 | $21M | 5.0M | 4.26 | |
Amgen | 2.9 | $18M | 210k | 86.20 | |
Hca Holdings (HCA) | 2.8 | $17M | 578k | 30.17 | |
Shire | 2.6 | $17M | 180k | 92.18 | |
ViroPharma Incorporated | 2.5 | $16M | 686k | 22.76 | |
EXACT Sciences Corporation (EXAS) | 2.3 | $15M | 1.4M | 10.59 | |
Neptune Technologies Bioreso | 1.8 | $11M | 5.6M | 2.01 | |
Gilead Sciences (GILD) | 1.7 | $11M | 143k | 73.45 | |
Synta Pharmaceuticals | 1.4 | $9.0M | 993k | 9.02 | |
Celgene Corporation | 1.3 | $8.2M | 105k | 78.47 | |
Covidien | 1.2 | $7.6M | 132k | 57.74 | |
Novartis (NVS) | 1.1 | $6.6M | 104k | 63.30 | |
PROLOR Biotech | 1.0 | $6.4M | 1.3M | 4.95 | |
Tenet Healthcare Corporation (THC) | 0.9 | $5.5M | 170k | 32.47 | |
Lexicon Pharmaceuticals | 0.8 | $5.3M | 2.4M | 2.21 | |
Athersys | 0.8 | $4.7M | 4.5M | 1.06 | |
Cutera (CUTR) | 0.6 | $4.0M | 445k | 9.00 | |
Supernus Pharmaceuticals (SUPN) | 0.6 | $3.9M | 550k | 7.17 | |
Pharmacyclics | 0.6 | $3.5M | 60k | 57.78 | |
OSI Systems (OSIS) | 0.5 | $3.2M | 50k | 64.04 | |
Dyax Corp | 0.5 | $3.2M | 912k | 3.48 | |
Keryx Biopharmaceuticals | 0.5 | $3.0M | 1.1M | 2.62 | |
Cempra | 0.5 | $2.9M | 450k | 6.40 | |
Mylan | 0.4 | $2.7M | 100k | 27.46 | |
Uroplasty | 0.4 | $2.3M | 693k | 3.25 | |
MAKO Surgical | 0.4 | $2.2M | 175k | 12.85 | |
ZIOPHARM Oncology | 0.3 | $2.1M | 500k | 4.16 | |
Neostem (NBS) | 0.3 | $2.0M | 3.3M | 0.60 | |
Acadia Pharma Inc CS Usd0.0001 | 0.3 | $1.9M | 400k | 4.65 | |
Protalix BioTherapeutics | 0.3 | $1.8M | 356k | 5.19 | |
Tekmira Pharmaceuticals Corporation | 0.3 | $1.6M | 320k | 5.01 | |
Anthera Pharmaceuticals | 0.2 | $1.4M | 2.2M | 0.62 | |
Astex Pharmaceuticals | 0.2 | $1.3M | 430k | 2.91 | |
Transgenomic | 0.2 | $1.2M | 2.0M | 0.61 | |
Dynavax Technologies Corporation | 0.2 | $1.1M | 400k | 2.85 | |
Sunrise Senior Living | 0.2 | $1.0M | 73k | 14.38 | |
Questcor Pharmaceuticals | 0.2 | $1.1M | 40k | 26.72 | |
ISIS Pharmaceuticals | 0.2 | $1.0M | 100k | 10.44 | |
Alere | 0.2 | $1.0M | 55k | 18.51 | |
Conceptus | 0.1 | $824k | 39k | 21.00 | |
MAP Pharmaceuticals | 0.1 | $783k | 50k | 15.66 | |
Mgc Diagnostics | 0.1 | $726k | 123k | 5.90 | |
XOMA CORP Common equity shares | 0.1 | $701k | 292k | 2.40 | |
Abbvie (ABBV) | 0.1 | $683k | 20k | 34.15 | |
RTI Biologics | 0.1 | $598k | 140k | 4.27 | |
DARA BioSciences | 0.1 | $578k | 750k | 0.77 | |
Cynosure | 0.1 | $482k | 20k | 24.10 | |
Oncothyreon | 0.1 | $380k | 198k | 1.92 | |
Amarin Corporation | 0.1 | $405k | 50k | 8.10 | |
INSTRS INC Stemcells | 0.1 | $378k | 232k | 1.63 | |
Puma Biotechnology (PBYI) | 0.1 | $375k | 20k | 18.75 | |
Cell Therapeutics | 0.1 | $359k | 276k | 1.30 | |
Celldex Therapeutics | 0.0 | $222k | 33k | 6.71 | |
Spectranetics Corporation | 0.0 | $223k | 15k | 14.77 | |
Spectrum Pharmaceuticals | 0.0 | $189k | 17k | 11.18 | |
Sunesis Pharmaceuticals | 0.0 | $210k | 50k | 4.20 | |
Pacific Biosciences of California (PACB) | 0.0 | $128k | 75k | 1.71 | |
Verastem | 0.0 | $104k | 12k | 8.80 | |
Merck & Co (MRK) | 0.0 | $49k | 1.2k | 40.83 | |
Trinity Biotech | 0.0 | $3.0k | 200.00 | 15.00 | |
EnteroMedics | 0.0 | $14k | 5.0k | 2.80 | |
Genvec | 0.0 | $19k | 14k | 1.36 | |
Combimatrix Corporation *w exp 05/01/ | 0.0 | $2.0k | 5.0k | 0.40 |